The number of people with susceptibility test result for rifampicin in Lithuania
Lithuania: The number of people with susceptibility test result for rifampicin was 100 in 2021. ▬ Flat
Latest (2021)
100
Change on year
unchanged
World rank
2nd
of 146 countries
All-time high
100
in 2017
All-time low
100
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Lithuania, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Lithuania is 100, measured in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is unchanged over five years.
That places Lithuania 2nd out of 146 countries with data for 2021, putting it in the top 10%.
The number of people with susceptibility test result for rifampicin in Lithuania, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 100 | — |
| 2018 | 100 | +0.0% |
| 2019 | 100 | +0.0% |
| 2020 | 100 | +0.0% |
| 2021 | 100 | +0.0% |
Lithuania compared with similar countries
- Lithuania's 100 is above the median for high income countries, which is 92.6, 1.1× the median. (56 countries reporting)
- Lithuania's 100 is above the median for Europe & Central Asia, which is 93.52, 1.1× the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 100 | 100 | 100 | 3 |
| 2020s | 100 | 100 | 100 | 2 |
Countries ranked near Lithuania
- 1 Italy 115.63 compare
- 2 Northern Mariana Islands 100 compare
- 2 Jamaica 100 compare
- 2 Lao People's Democratic Republic 100 compare
- 2 Israel 100 compare
- 2 Qatar 100 compare
- 2 Bahamas 100 compare
- 2 Brunei Darussalam 100 compare
- 2 Tonga 100 compare
- 2 Armenia 100 compare
- 2 Palau 100 compare
- 2 Tuvalu 100 compare
- 2 Uzbekistan 100 compare
- 2 Tajikistan 100 compare
- 2 Chad 100 compare
- 2 Bermuda 100 compare
- 2 Mauritius 100 compare
- 2 Eswatini 100 compare
- 2 Belarus 100 compare
- 2 New Caledonia 100 compare
- 2 Andorra 100 compare
- 2 Montenegro 100 compare
- 2 Naoero 100 compare
- 2 Micronesia, Federated States of 100 compare
- 2 Seychelles 100 compare
- 2 Marshall Islands 100 compare
- 2 Saint Lucia 100 compare
- 2 Mongolia 100 compare
- 2 Kuwait 100 compare
- 2 North Macedonia 100 compare
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,909 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -4.51 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0199 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.59 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Lithuania?
- The number of people with susceptibility test result for rifampicin in Lithuania was 100 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Lithuania?
- The highest recorded value was 100 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Lithuania?
- The lowest recorded value was 100 in 2017.
- How does Lithuania rank for the number of people with susceptibility test result for rifampicin?
- Lithuania ranks 2nd out of 146 countries with data for 2021.
- Where does this Lithuania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).